Who Owns Biohaven Stock?
NYSE: BHVNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 95.71%
- Institutions (% of float)
- 107.79%
- Held by insiders
- 11.21%
- Institutional holders
- 376
- Institutions 88.8%
- Insiders 11.2%
- Public and other 0.0%
Who owns Biohaven stock?
Institutional investors own about 95.7% of Biohaven's shares, spread across 376 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 11.21% of BHVN.
The largest institutional holders are Blackrock Inc. (8.75%), Montanova Capital LLC (6.81%) and Stifel Financial Corporation (6.58%). Together, the top 10 institutions control 49.4% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their BHVN positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of BHVN
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 13.21M | 8.75% | +17.7% |
| Montanova Capital LLC | 10.29M | 6.81% | 0.0% |
| Stifel Financial Corporation | 9.94M | 6.58% | 0.0% |
| Jupiter Topco LLC | 8.58M | 5.68% | +100.0% |
| Woodline Partners LP | 7.66M | 5.07% | +2450.1% |
| State Street Corporation | 6.95M | 4.60% | +5.0% |
| Infinitum Asset Management, LLC | 6.25M | 4.14% | 0.0% |
| Shaw D.E. & Co., Inc. | 4.19M | 2.77% | +47.2% |
| AQR Capital Management, LLC | 4.15M | 2.75% | +110.1% |
| Geode Capital Management, LLC | 3.32M | 2.20% | +20.1% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of BHVN
| Fund | Shares | % Held |
|---|---|---|
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 4.00M | 2.65% |
| iShares Trust-iShares Russell 2000 ETF | 3.42M | 2.27% |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 2.18M | 1.44% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.49M | 0.99% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.46M | 0.97% |
| JANUS INVESTMENT FUND-Janus Henderson Global Life Sciences Fund | 1.33M | 0.88% |
| iShares Trust-iShares Russell 2000 Growth ETF | 1.24M | 0.82% |
| SmallCap World Fund Inc | 1.17M | 0.77% |
| JANUS INVESTMENT FUND-Janus Henderson Triton Fund | 1.16M | 0.77% |
| Simplify Exchange Traded Funds-Simplify Health Care ETF | 1.04M | 0.69% |
Frequently asked questions
Who is the largest shareholder of Biohaven?
Blackrock Inc. is the largest institutional shareholder of BHVN, owning 8.75% of shares outstanding (13.21M shares) as of its latest 13F filing.
What percentage of Biohaven is owned by institutions?
Institutions own about 95.7% of BHVN shares and 107.8% of the public float.
How much of Biohaven do insiders own?
Insiders, such as officers and directors, own about 11.21% of BHVN shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.